-fiban
Antiplatelet drugs that block the glycoprotein IIb/IIIa receptor.
- Drugs ending in -fiban: 2
- Approved somewhere: 1
- With a US drug page: 1
- Stem
- -fiban
- Class
- Antiplatelet drugs that block the glycoprotein IIb/IIIa receptor
- Most common targets
- ITGA2B, ITGB3 (2)
Approved and clinical-stage drugs in ChEMBL whose names ending in -fiban, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Tirofiban | Approved | ITGA2B, ITGB3 | Integrin alpha-IIb/beta-3 inhibitor |
| Zalunfiban | Phase 3 | ITGA2B, ITGB3 | Integrin alpha-IIb/beta-3 inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO